Duke in DC and Duke Health Government Relations convened a group of Duke experts to brief federal policymakers on the importance of federal investment in research, the impacts from their work, and additional recommendations to bolster our nation’s public health, medical preparedness, and response systems

Researchers have developed a novel mobile health (mHealth) tympanometer with a machine learning interface which they believe will have broad applicability and has the potential to improve diagnoses in community health settings, where access to a specialist can be limited.

The Duke Cancer Institute is excited to announce the establishment of the Duke Sarcoma Center, a center of excellence for sarcoma treatment and research.

As Duke celebrates its 50th anniversary of transforming cancer discovery and care, researchers and providers envision a future when all cancers are easily treatable; physicians can detect and stop cancer earlier and earlier; and everyone has the same opportunity to survive cancer.

Duke University School of Medicine is proud to acknowledge the faculty members who were selected as recipients of this year’s School of Medicine faculty awards. These are just a few of the awards and recognitions afforded to our community members and we want to congratulate them on these well-deserved honors. Congratulations to the following 2022 Duke School of Medicine Award recipients!

Rasheed Gbadegesin, MD, MBBS, and Patty J. Lee, MD, have been elected to the Association of American Physicians (AAP). They were inducted during the joint meeting of the AAP, the American Society for Clinical Investigation (ASCI), and the American Physician-Scientists Association (APSA) on April 8, 2022.

Christopher C. Beyrer, MD, MPH, an internationally recognized epidemiologist who has worked on the front lines of HIV/AIDS and COVID-19 treatment and research, will be the next director of the Duke Global Health Institute (DGHI).

Biochemistry PhD students tutor high school students in the Emily Krzyzewski Center's Scholars to College program.

A team led by researchers at the Duke Cancer Institute identified a potential new tactic to disrupt the repair mechanism that cancer cells use after treatment, blunting their ability to regenerate. The approach could present a new treatment strategy.

One of Dr. Kimberly Johnson’s earliest memories of arriving at Duke for her residency in 1997 is the long hallways lined with portraits of white men. Johnson, professor of medicine, has since earned her own place in the hallowed halls of Duke—and beyond.